Sony Pictures has picked up the rights to "The Surgeon," an action-driven horror thriller that will star Michelle Yeoh, the studio confirmed Tuesday. The project, which has been circulating in Hollywood for several months, gives Yeoh another leading vehicle as she continues to capitalize on the career resurgence that followed her Academy Award win for "Everything Everywhere All at Once."
Details about the plot remain under wraps, but the title and genre suggest a blend of high-stakes combat and medical terror. Sony has not announced a director or a release date, and it is unclear whether the film will be positioned for theaters or a streaming debut.
The acquisition marks another notable genre play for Sony, which has found success in recent years with mid-budget thrillers and horror titles that perform well with audiences. Yeoh's involvement gives "The Surgeon" an immediate international profile, particularly in markets where her action work has long been a draw.
Yeoh, 64, has spent the past several years balancing blockbuster franchise roles with more personal projects. She appeared in "Avatar: The Way of Water" and its sequels, and has been attached to a number of high-profile packages since her Oscar win. "The Surgeon" would add a darker, more visceral entry to that filmography, one that trades on the physicality and intensity she has brought to roles in "Crouching Tiger, Hidden Dragon" and "Supercop."
The premise of a medical professional operating outside the bounds of ethics is not new to cinema. The 1995 film "The Surgeon" - an unrelated horror and science fiction production directed by Carl Schenkel - centered on Dr. Julian Matar, a physician whose license is revoked after he performs cellular regeneration experiments on dying patients. He returns to the hospital that condemned him two years later to resume his work. That film, which ran 99 minutes and starred Isabel Glasser, James Remar, Sean Haberle, Peter Boyle and Malcolm McDowell, holds a modest 5.065 out of 10 rating on TMDb.
Sony's project is not a remake of that film, according to a person familiar with the deal, though the shared title has already prompted confusion online. The new "The Surgeon" is described as an action movie with horror elements, built around a lead role that will require both dramatic range and fight choreography.
Yeoh has been vocal about seeking roles that challenge her beyond the martial arts performances that first made her a star in Hong Kong cinema. In recent interviews, she has said she wants to work with filmmakers who can use her in unexpected ways. "The Surgeon" appears designed with that in mind - a character who operates in a morally gray world, where the line between healer and predator is deliberately blurred.
Sony has not commented on the casting process or the film's production timeline. The studio is expected to make further announcements in the coming weeks, including a director and a start date.
For Yeoh, the role continues a busy period. She is also attached to several other projects in various stages of development, and her schedule will likely determine when "The Surgeon" moves forward. The film's genre positioning - horror with action - could place it in a release window that targets both audiences, a strategy that has worked for titles like "The Equalizer" and "Nobody."
The original "The Surgeon" was released on January 13, 1995, in English and produced within the Hollywood system. It arrived at a time when medical horror was a reliable subgenre, though the film itself did not achieve lasting commercial success. Its cult reputation has grown modestly in the years since, largely among fans of Schenkel's work and of the cast, which included Peter Boyle and Malcolm McDowell in supporting roles.
Whether Sony's "The Surgeon" will draw any inspiration from that earlier film remains to be seen. The studio has not indicated any connection beyond the title, and the new project is being developed as an original story. For now, the main takeaway is that Yeoh has found another leading role in a genre she has rarely explored on this scale - and that Sony has added a potentially commercial title to its slate.
Further details, including additional cast and a release plan, are expected as the project moves through development.
Source: The Hollywood Reporter
